FDA Application
-
NDC Search Results on Active Ingredient: ibuprofen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
IBUPROFEN | 0573-0154-89 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE | 0573-0190-02 | Haleon US Holdings LLC | NDA022113 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0160-41 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
DIPHENHYDRAMINE CITRATE; IBUPROFEN | 0573-0164-04 | Haleon US Holdings LLC | NDA021394 | HUMAN OTC DRUG | NDA |
IBUPROFEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE | 0573-0196-02 | Haleon US Holdings LLC | NDA022113 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0151-30 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0161-35 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0151-21 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0160-42 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0149-66 | Haleon US Holdings LLC | NDA020402 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0150-30 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0154-59 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0149-04 | Haleon US Holdings LLC | NDA020402 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0151-10 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0169-40 | Haleon US Holdings LLC | NDA020402 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0169-02 | Haleon US Holdings LLC | NDA020402 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0290-01 | Haleon US Holdings LLC | NDA020589 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0170-01 | Haleon US Holdings LLC | NDA020589 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0133-01 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0151-20 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0149-91 | Haleon US Holdings LLC | NDA020402 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0161-51 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0154-84 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-1769-80 | Haleon US Holdings LLC | NDA020402 | HUMAN OTC DRUG | NDA |
DIPHENHYDRAMINE CITRATE; IBUPROFEN | 0573-0164-33 | Haleon US Holdings LLC | NDA021394 | HUMAN OTC DRUG | NDA |
IBUPROFEN; ACETAMINOPHEN | 0573-0147-95 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0150-31 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0150-42 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0133-81 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE | 0573-0199-03 | Haleon US Holdings LLC | NDA022565 | HUMAN OTC DRUG | NDA |
-